A vaccine usually trains your immune system to recognize one target. Here, the target is basically “anything that doesn’t ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect against one ...

Researchers at Stanford University are leading efforts on a one-of-a-kind universal nasal respiratory vaccine.

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...

In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

Researchers have invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens – the closest yet ...

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

A new Stanford study published Thursday marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect ...

The MarketWatch News Department was not involved in the creation of this content. A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data ...